PDF

摘要/Abstract

摘要：

背景与目的：肿瘤细胞免疫逃逸是肿瘤治疗中的难点，而肿瘤细胞中自噬过度激活会引起肿瘤细胞表面抗原的增加，参与抗肿瘤免疫。本研究通过临床样本检测结直肠癌中自噬关键因子微管相关蛋白轻链3（light chain 3，LC3）表达、成熟树突状细胞（mature dendritic cell，mDC）数目及三级淋巴结构（tertiary lymphoid structure，TLS）的形成，探讨其相关性及临床意义，旨在为增强抗肿瘤免疫治疗提供新思路。方法：采用免疫组织化学EnVision法检测2016年1月—2017年6月滨州医学院附属医院收治的经手术切除的179例T₂期高危及T₃期结直肠癌患者的癌组织及癌旁组织中LC3、DC-lamp的表达和TLS的形成。采用蛋白质印迹法（Western blot）及实时荧光定量聚合酶链反应（real-time fluorescence quantitative polymerase chain reaction，RTFQ-PCR）检测TLS⁺及TLS^-结直肠癌组织中LC3、NY-ESO-2、淋巴毒素β（lymphotoxin-beta，LTβ）、CC族趋化因子配体21（CC chemokine ligand 21，CCL21）、CXC族趋化因子配体13（CXC chemokine ligand 13，CXCL13）及白细胞介素17（interleukin-17，IL-17）的表达，分析其相关性及临床意义。采用log-rank检验比较组间预后差异，采用COX比例风险回归模型进行多因素生存分析。结果：结直肠癌组织中LC3、DC-lamp的表达量均高于癌旁组织（P<0.05），LC3与DC-lamp的表达呈正相关（P<0.05）。TLS⁺组中LC3、NY-ESO-2、LTβ、CXCL13及CCL21的蛋白水平及mRNA表达均高于TLS^-组（P <0.05），而IL-17的表达量则低于TLS^-组（P<0.05），LC3表达与TLS/生发中心（germinal center，GC）⁺、TLS/GC^-两亚型均呈正相关（P <0.05），且与NY-ESO-2、LTβ、CXCL13及CCL21的表达呈正相关（P<0.05）。DC-lamp在TLS/GC⁺和TLS/GC^-亚型组中的表达量均高于其余两亚组（P<0.05），且呈正相关（P<0.05）。Log-rank检验及COX比例风险回归模型显示，结直肠癌中LC3、DC-lamp、TLS及淋巴结转移与结直肠癌患者的预后密切相关，且均是结直肠癌预后的独立危险因素。结论：结直肠癌中LC3异常表达可通过增加表面抗原激活mDC，进而募集淋巴细胞，促进TLS的形成与成熟，最终影响患者的预后。

关键词: 结直肠肿瘤, 轻链3, 成熟树突状细胞, 三级淋巴结构, 临床意义

Abstract:

Background and purpose: It has been recognized as a complex problem in tumor therapy to deal with the tumor immune escape, and over-activated autophagy can cause the increase of tumor surface antigen, which participates in anti-tumor immunity. In this study, the expressions of microtubule-associated protein light chain 3 (LC3), mature dendritic cell (mDC) and the formation of tertiary lymphoid structure (TLS), an essential autophagy factor in colorectal cancer, were detected in clinical samples. The results had important clinical implications and provided new insights for enhancing anti-tumor immunity. Methods: Immunohistochemical EnVision method was used to detect the expressions of LC3, DC-lamp and the formation of TLS in cancer tissues and normal mucosal tissues of 179 patients with T₂ stage high-risk and T₃ stage colorectal cancer who underwent surgical resection at Binzhou Medical University Hospital from January 2016 to June 2017. Western blot and real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) were used to detect the expressions of LC3, NY-ESO-2, lymphotoxin-beta (LTβ), CC chemokine ligand 21 (CCL21), CXC chemokine ligand 13 (CXCL13) and interleukin-17 (IL-17) in TLS⁺ and TLS^- colorectal cancer tissues. Then the correlation and clinical significance were analyzed. Log-rank test was used to compare the prognostic differences between groups, and COX proportional risk regression model was used for multivariate survival analysis. Results: Clinical samples showed that the expressions of LC3 and DC-lamp were higher in colorectal cancer tissues than in normal mucosa tissues (P<0.05), and the expressions of LC3 and DC-lamp were positively correlated (P<0.05). The protein and mRNA expressions of LC3, NY-ESO-2, LTβ, CXCL13 and CCL21 were higher in TLS⁺ group than in TLS^- group. The expression of IL-17 was higher in the TLS^- group than in the TLS⁺ group (P<0.05). The expression of LC3 was positively correlated with TLS/germinal center (GC)⁺ and TLS/GC^- subtypes and positively correlated with the expression of NY-ESO-2, LTβ, CXCL13 and CCL21 (P<0.05). The expression of DC-lamp was higher in TLS/GC⁺ and TLS/GC^- subtype groups than in the other two subgroups (P<0.05), and there was a positive correlation. Kaplan-Meier and COX regression models showed that LC3, DC-lamp, TLS and lymph node metastasis were closely related to the prognosis of patients with colorectal cancer, and they were independent risk factors for the prognosis of colorectal cancer. Conclusion: The abnormal expression of LC3 in colorectal cancer can activate mDC to recruit lymphocytes and promote the expression and maturation of TLS, ultimately affecting the prognosis of patients.

Key words: Colorectal cancer, Light chain 3, Mature dendritic cell, Tertiary lymphoid structure, Clinical significance

中图分类号:

武寒, 徐磊, 王苗苗, 张睿哲, 许晓阳, 郭宁杰, 吴淑华. 结直肠癌中LC3与树突状细胞募集、TLS形成的相关性及其临床意义[J]. 中国癌症杂志, 2023, 33(9): 818-828.

WU Han, XU Lei, WANG Miaomiao, ZHANG Ruizhe, XU Xiaoyang, GUO Ningjie, WU Shuhua. Correlation of LC3 and the recruitment of dendritic cell and the formation of TLS in colorectal cancer and its clinical significance[J]. China Oncology, 2023, 33(9): 818-828.

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://www.china-oncology.com/CN/10.19401/j.cnki.1007-3639.2023.09.002

http://www.china-oncology.com/CN/Y2023/V33/I9/818

[1]	崔忠泽, 何双, 温菲菲, 李扬扬, 许晓阳, 路丽祯, 吴淑华. 干预自噬影响DPD的表达促进5-FU抗结直肠癌疗效的实验研究[J]. 中国癌症杂志, 2022, 32(12): 1199-1209.
[2]	贾真真, 何双, 李扬扬, 温菲菲, 许晓阳, 郭宁杰, 吴淑华. 结直肠癌中DPD与LC3、P62表达的相关性及其临床意义[J]. 中国癌症杂志, 2022, 32(1): 24-33.
[3]	蒋梦怡 , 陆言巧 , 王红霞 . 乳腺癌异质性的研究进展及临床意义[J]. 中国癌症杂志, 2020, 30(5): 394-400.
[4]	张娜，林岩松，梁军. 甲状腺球蛋白抗体测定在分化型甲状腺癌¹³¹I治疗中的临床意义[J]. 中国癌症杂志, 2019, 29(6): 452-456.
[5]	段雅晨,陈小军,吴小华. HPV的外周循环血测定及临床意义[J]. 中国癌症杂志, 2017, 27(11): 908-912.
[6]	童　朵,张　文. 阿司匹林与大肠癌防治及其相关机制研究进展[J]. 中国癌症杂志, 2016, 26(9): 795-800.
[7]	刘　锋,谢黎明,张志伟,等. miR-124在胃癌中的表达及临床意义[J]. 中国癌症杂志, 2016, 26(3): 215-220.
[8]	胡　强,熊　华,房静远. 大肠癌表观遗传修饰在东西方人口中的异同研究[J]. 中国癌症杂志, 2016, 26(2): 182-187.
[9]	倪怀坤. 对Ⅲ期低位直肠癌行择区扩大淋巴结清扫的临床意义[J]. 中国癌症杂志, 2015, 25(11): 917-920.
[10]	张冉冉,连海峰,刘成霞. microRNA-486对结直肠癌裸鼠皮下移植瘤生长抑制作用及其机制的研究[J]. 中国癌症杂志, 2015, 25(10): 802-806.
[11]	吴巍芸,周宇. miR-192与ZEB2在结直肠癌中的表达及其临床意义[J]. 中国癌症杂志, 2014, 24(7): 507-511.
[12]	余绮荷,张文. MicroRNA与结直肠癌化疗关系的研究进展[J]. 中国癌症杂志, 2014, 24(1): 62-68.
[13]	刘博,田延锋,赵增仁,樊智彬,张丽静,贺新奇,高利飞. 微小RNA-187*在结直肠癌组织中表达及其对结肠癌细胞凋亡的影响[J]. 中国癌症杂志, 2013, 23(9): 703-708.
[14]	盛伟琪. 个体化治疗对结直肠癌病理诊断和分期的新要求[J]. 中国癌症杂志, 2013, 23(4): 315-320.

结直肠癌中LC3与树突状细胞募集、TLS形成的相关性及其临床意义

PDF

摘要/Abstract

引用本文

使用本文

相关文章